Rifampin Capsule
Lupin Pharmaceuticals, Inc. · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 12/22/2021
- Package NDC
- 68180-658-06
- Generic name
- Rifampin Capsule
- Contact info
- 866-587-4617
- Availability
- Available
- Update date
- 09/01/2026
- Dosage form
- Capsule
- Presentation
- Rifampin, Capsule, 150 mg (NDC 68180-658-06)
- Company name
- Lupin Pharmaceuticals, Inc.
- Status
- Current
- Therapeutic category
- Anti-Infective
- Harmonized identifiers (openFDA)
- Application number
- ANDA090034
- Brand name
- RIFAMPIN
- Generic name
- RIFAMPIN
- Manufacturer name
- Lupin Pharmaceuticals, Inc.
- Product NDC
- 68180-658, 68180-659
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- RIFAMPIN
- RxCUI
- 198201, 198202
- SPL ID
- 5ed1edac-e11e-4f87-b390-e770a69a9b37
- SPL set ID
- b56004f0-f23d-47f6-80c7-39884fccbccc
- Package NDC
- 68180-658-06, 68180-658-01, 68180-659-06, 68180-659-07, 68180-659-01
- Nui
- N0000175500, M0019113
- Pharm class epc
- Rifamycin Antibacterial [EPC]
- Pharm class cs
- Rifamycins [CS]
- UNII
- VJT6J7R4TR